CollPlant (CLGN) VP details option and restricted share unit holdings
Rhea-AI Filing Summary
CollPlant Biotechnologies Ltd VP of Product Development Jasmine Seror has filed an initial Form 3 outlining her equity-based holdings in the company. The filing lists several option grants to purchase Ordinary Shares and restricted share unit awards, all reported as directly owned.
Seror holds options over 4,000 and 1,000 Ordinary Shares with an exercise price of $4.0200 per share, and additional options over 5,000, 6,000 and 3,600 Ordinary Shares at $6.3900 per share, with expirations between 2027 and 2032. She also holds 12,000 restricted share units, of which 5,250 are vested and 6,750 vest in nine equal quarterly installments from June 8, 2026 to June 8, 2028, and a further 45,000 restricted shares vesting over three years, with 33% vesting on November 25, 2026 and the remaining 67% in eight equal quarterly installments. One option grant is described as fully vested and exercisable.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Footnotes (1)
- To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's Share Ownership and Option Plan (2010) or 2024 Share Award Plan must be registered in the name of a trustee. Of the restricted share units reported herein, 5,250 units are vested, and the remaining 6,750 units vest in nine equal quarterly installments beginning June 8, 2026 and ending June 8, 2028, subject to the Reporting Person's continued service to the Issuer as of such vesting date. The restricted shares shall vest over a period of 3 years: 33% shall vest on November 25, 2026, and the remaining 67% shall vest in eight equal quarterly installments thereafter. Fully vested and exercisable.
